Description
Retatrutide (LY3437943) is a synthetic, long-acting triagonist peptide that simultaneously activates the glucose‑dependent insulinotropic polypeptide receptor (GIPR), glucagon‑like peptide‑1 receptor (GLP‑1R), and glucagon receptor (GCGR).




